ORYLMYTE 100 IR, sublingual tablet 15 tablets
Active ingredients: EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES FARINAE, EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES PTERONYSSINUS
Commercialized according to BDPMDispensing in France: Prescription only
Tablet15 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORYLMYTE 100 IR, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquette(s) PVC aluminium OPA : polyamide orienté de 15 comprimé(s)
- Marketing authorisation holder
- STALLERGENES
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
67002300CIP73023600CIP133400930236000Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES PTERONYSSINUScomprimé | 50 IR · un comprimé | SA |
| EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES FARINAEcomprimé | 50 IR · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.